Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
Clinical trial NCT07310290 · RECRUITING
Trial details
- NCT number
- NCT07310290
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-27
- Primary completion
- 2027-03-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.